i5 Coronavirus Health Risk Calculator - Major Upgrade

i5 Health最近以“无偿”的方式创建了i5冠状病毒健康风险计算器（“计算器”），可从[https://www.coronavirusrisk.org/][0]]获取。它确定一个人是否属于四个健康风险类别中的一个：低、中、高和非常高。i5计算器已经使用了超过10万次，4月9日，伦敦最大的NHS委托支持单位NEL CSU成功地为410万伦敦人使用了该工具。计算器的用途很多。这些措施包括个人决定自己的隔离级别、护理的优先次序、改善床位管理（特别是在ICU环境下）、支持远程会诊、制定疾病控制计划和放宽限制。随着2019冠状病毒病浪潮的延续，另一波浪潮随之而来，并且每年都会再次发生，当局还需要获取每个地方个人风险水平的信息，以实施疾病控制和社会隔离战略。为了更好地满足所有这些需求，计算器需要快速升级。这样做的机会在于，Covid-19是一种以前闻所未闻的冠状病毒株，其特征直到现在才真正被了解。创建当前计算器背后的研究不得不依赖于这种新疾病的两个近亲——“人类”冠状病毒和流感——的医院二级护理数据。入院的Covid-19患者的数据将在2020年4月底之前公布，我们必须准备好对其进行分析，以获得更多见解，以确保尽快调整计算器的算法，对人群进行分层和保护。在下一次迭代中，我们可以在NHS的合作下，利用额外的全科医生关于病人的初级保健数据。此外，我们可以利用分配的时间和资源，确保将高和非常高类别的结果与提供住院时间、住院天数和ICU需求等关键因素的预测联系起来。为了加快升级计算器的市场速度，无论是在英国还是在国际上，并扩大其积极影响，我们认为有必要延长项目的期限，以进一步投资于升级计算器的营销，特别是在英国以外，将其商业化。原因是：-正如我们在项目开始时预测的那样，大流行正在经历显着增长，并可能在可预见的未来与我们一起-使升级后的计算器成为对抗COVID-19影响的越来越重要的工具-对于中小型企业而言，计算器的营销和商业化在财务上具有挑战性，因此我们必须：为其营销和商业化使用寻找资金——鉴于COVID-19的全球性质，计算器可以成为一项重要的出口服务——为英国带来收入，并加强英国在先进卫生技术方面的声誉；这将符合国际贸易部和卫生和社会保障部的战略，这些部门由它们共同拥有的组织“英国保健”所代表。[0]: https://www.coronavirusrisk.org/e

i5 Health, on a 'pro bono' basis, has recently created the i5 Coronavirus Health Risk Calculator ("Calculator") accessible from [https://www.coronavirusrisk.org/][0]. It establishes whether a person falls into one of four health risk categories: Low, Medium, High and Very High. The i5 Calculator has already been used over 100,000 times and, on 9th April, the largest NHS Commissioning Support Unit for London, NEL CSU, successfully used the tool for 4.1 million Londoners.The uses of the Calculator are many. These include individuals deciding their level of quarantine, the prioritising of care, improvement in bed management particularly in the ICU context, supporting remote consultations, planning for disease control and relaxation of restrictions.With the prospect of Covid-19 wave extending, another wave following and re-occurrences happening each year, there is the additional need for authorities to source information on risk levels of individuals in every location to execute disease control and Social Isolation strategies. To fulfil better all these needs, the Calculator requires rapid upgrading.The opportunity for so doing lies in the fact that that Covid-19 is a previously unheard of strain of Coronavirus - the characteristics of which are only really now being understood. Research behind the creation of the current Calculator had to rely on hospital secondary care data on two close relatives of the new disease - 'human' Coronavirus and Influenza. The data arising from hospital admitted Covid-19 patients will be released before the end of April 2020 and we must be prepared to analyse it for additional insights in order to ensure adjustments to the Calculator's algorithms as quickly as possible, to stratify and protect the population.For the next iteration, we can, with the co-operation of the NHS, draw on additional GP primary care data about the patients. In addition, we can use the time and resources allotted to ensure the linking of outcomes for the High and Very High categories to providing forecasts on key factors like lengths of stay, bed days and ICU needs.In order to increase speed to market of the upgraded Calculator, both in the UK and internationally, and extend its positive impacts, we believe it is necessary to prolong the period of the project to invest further in marketing the upgraded Calculator and, specifically outside the UK, to commercialise it. The reasons are:- As we predicted at the start of the project, the pandemic is experiencing significant growth and is likely to be with us for the foreseeable future – making the upgraded Calculator an increasingly important tool in combatting the effects of COVID-19- For the SME i5, such marketing and commercialisation of the Calculator becomes financially challenging and we must, therefore, find funding for its marketing and commercialisation of its use- Given the worldwide nature of COVID-19, the Calculator could be an important export service – bringing revenues to the UK and reinforcing the UK’s reputation in advanced health technology; this would fit within the strategies of the Department for International Trade and the Department of Health and Social Care represented by their jointly owned organisation, Healthcare UK.[0]: https://www.coronavirusrisk.org/e